Literature DB >> 16808151

Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Cheon Ho Park1, Su Duy Nguyen, Mee Ree Kim, Tae-Sook Jeong, Dai-Eun Sok.   

Abstract

Interaction of paraoxonase1 (PON1) with lysophospholipids was examined with respect to activity regulation and binding property. Paraoxonase activity of purified PON1 was partially inhibited by palmitoyl-lysophosphatidyl-glycerol (palmitoyl-lysoPG) and lysophosphatidylinositol (lysoPI), which had a stimulatory effect on arylesterase and diazoxonase activities. The selective inhibition of paraoxonase activity by palmitoyl-lysoPG, characterized by noncompetitiveness and charge interaction, was also observed with HDL- or dimyristoylphosphatidylcholine (DMPC)-bound PON1. Meanwhile, lysophosphatidylcholine (lysoPC) stimulated all three activities of purified PON1, although it stimulated DMPC-bound or HDL-bound PON1 to a lesser extent. The stimulatory action of lysophospholipids was observed around their CMC, suggesting that micelle formation of lysophospholpids might be involved in the stimulation of PON1 activity. Presumably in support of this, the tryptophan fluorescence intensity of PON1 was increased by lysophospholipids at concentrations required for the stimulation of PON1 activity. Separately, lysoPC stimulation was less remarkable for DMPC-bound PON1 than for either dimyristoylphosphatidylserine (DMPS)- or dimyristoylphosphatidylglycerol-bound PON1, suggesting a tight association between PON1 and DMPC. In support of this, the stimulatory role of apolipoprotein A-I was less prominent for DMPC-bound PON1 than for DMPS-bound PON1. Taken together, these data suggest that the inhibition of paraoxonase activity by lysoPG or lysoPI may be due to binding to a site distinct from the active center, whereas the stimulation by lysophospholipid may be ascribed to the micelle formation around the lipid-associable region of PON1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808151     DOI: 10.1007/s11745-006-5108-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  51 in total

1.  Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.

Authors:  Rakesh S Bargota; Mahmoud Akhtar; Keith Biggadike; David Gani; Rudolf K Allemann
Journal:  Bioorg Med Chem Lett       Date:  2003-05-19       Impact factor: 2.823

2.  Electrostatic and hydrophobic contributions to the folding mechanism of apocytochrome c driven by the interaction with lipid.

Authors:  S E Rankin; A Watts; T J Pinheiro
Journal:  Biochemistry       Date:  1998-09-08       Impact factor: 3.162

3.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

4.  Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.

Authors:  S Billecke; D Draganov; R Counsell; P Stetson; C Watson; C Hsu; B N La Du
Journal:  Drug Metab Dispos       Date:  2000-11       Impact factor: 3.922

5.  Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation.

Authors:  Orit Rozenberg; Diana M Shih; Michael Aviram
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-06       Impact factor: 8.311

6.  Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.

Authors:  David T Yeung; Denis Josse; James D Nicholson; Akhil Khanal; Christopher W McAndrew; Brian J Bahnson; David E Lenz; Douglas M Cerasoli
Journal:  Biochim Biophys Acta       Date:  2004-10-01

7.  Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 8.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

9.  Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.

Authors:  György Paragh; Petra Balla; Evelin Katona; Ildikó Seres; Anikó Egerházi; István Degrell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-04       Impact factor: 5.270

Review 10.  Paraoxonase, a cardioprotective enzyme: continuing issues.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2004-06       Impact factor: 4.776

View more
  2 in total

1.  The Early Effect of Carotid Artery Stenting on Antioxidant Capacity and Oxidative Stress in Patients with Carotid Artery Stenosis.

Authors:  Slawomir Michalak; Wojciech Ambrosius; Ewa Wysocka; Mieczyslaw Dziarmaga; Robert Juszkat; Andrzej Wykretowicz; Wojciech Kozubski
Journal:  Oxid Med Cell Longev       Date:  2016-12-13       Impact factor: 6.543

2.  Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL.

Authors:  Irene Schilcher; Julia T Stadler; Margarete Lechleitner; Andelko Hrzenjak; Andrea Berghold; Gudrun Pregartner; Marie Lhomme; Michael Holzer; Melanie Korbelius; Florian Reichmann; Anna Springer; Christian Wadsack; Tobias Madl; Dagmar Kratky; Anatol Kontush; Gunther Marsche; Saša Frank
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.